title: Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer's Disease.
abstract: Intra- and inter-laboratory variability of cerebrospinal fluid (CSF) biomarker analyses remains an important issue. We investigated the clinical-diagnostic impact of CSF biomarker concentration shifts in mild cognitive impairment (MCI) and autopsy-confirmed Alzheimer's disease (AD) dementia patients. MCI patients (n = 85), autopsy-confirmed AD dementia patients (n = 72), and cognitively healthy controls (n = 100) were included in this prospective, longitudinal study. AD dementia patients were followed up until death, and controls were included from 1992 until 2003. In-house validated cutoff values of biomarkers were applied: Aβ1-42 <638.5 pg/mL, T-tau>296.5 pg/mL, P-tau(181P) >56.5 pg/mL. Both increments and decrements (from ± 5% to ± 40% ) were added to the true (=observed) CSF biomarker values, imitating the anticipated differences in biomarker concentrations. Within certain limits, the clinical diagnostic performance of AD CSF biomarkers remains largely unchanged and clinical diagnostic accuracy deviated less than 8.2% from the reference when concentration shifts ranging between -20% and +20% were added to one of the three CSF biomarkers in MCI and autopsy-confirmed AD patients. Notwithstanding the fact that (pre- and post-)analytical parameters can affect the clinical classification, the present exploratory study provides evidence that for a specific context of use, the impact on clinical accuracy of biomarker concentration shifts might be lower than originally expected. In conclusion, induced shifts of ±20% in only one of the three biomarkers has limited impact on the clinical accuracy of AD CSF biomarkers in MCI and autopsy-confirmed AD patients when using the IWG-2 criteria.
authors.affiliation: Reference Center for Biological Markers of Dementia (BIODEM), Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Antwerpen, Belgium.
authors.forename: Ellis
authors.initials: E
authors.lastname: Niemantsverdriet
authors.affiliation: Reference Center for Biological Markers of Dementia (BIODEM), Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Antwerpen, Belgium.
authors.forename: Joery
authors.initials: J
authors.lastname: Goossens
authors.affiliation: Reference Center for Biological Markers of Dementia (BIODEM), Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Antwerpen, Belgium.
authors.forename: Hanne
authors.initials: H
authors.lastname: Struyfs
authors.affiliation: Biobank, Institute Born-Bunge, University of Antwerp, Antwerpen, Belgium.
authors.forename: Jean-Jacques
authors.initials: JJ
authors.lastname: Martin
authors.affiliation: Department of Neurology and Memory Clinic, Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken, Antwerpen, Belgium.
authors.forename: Johan
authors.initials: J
authors.lastname: Goeman
authors.affiliation: Reference Center for Biological Markers of Dementia (BIODEM), Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Antwerpen, Belgium.|Biobank, Institute Born-Bunge, University of Antwerp, Antwerpen, Belgium.|Department of Neurology and Memory Clinic, Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken, Antwerpen, Belgium.
authors.forename: Peter Paul
authors.initials: PP
authors.lastname: De Deyn
authors.affiliation: ADx NeuroSciences, Gent, Belgium.
authors.forename: Hugo
authors.initials: H
authors.lastname: Vanderstichele
authors.affiliation: Reference Center for Biological Markers of Dementia (BIODEM), Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Antwerpen, Belgium.|Department of Neurology and Memory Clinic, Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken, Antwerpen, Belgium.
authors.forename: Sebastiaan
authors.initials: S
authors.lastname: Engelborghs
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000134:cerebrospinal fluid* / Q000175:diagnosis*; D016229:Amyloid beta-Peptides / Q000134:cerebrospinal fluid*; D001344:Autopsy; D060825:Cognitive Dysfunction / Q000134:cerebrospinal fluid / Q000175:diagnosis; D004797:Enzyme-Linked Immunosorbent Assay; D015444:Exercise / Q000502:physiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D010446:Peptide Fragments / Q000134:cerebrospinal fluid*; D011569:Psychiatric Status Rating Scales; D012189:Retrospective Studies; D018709:Statistics, Nonparametric; D016875:tau Proteins / Q000134:cerebrospinal fluid*
chemical_list: D016229:Amyloid beta-Peptides; D010446:Peptide Fragments; C075222:amyloid beta-protein (1-42); D016875:tau Proteins
keywords: (pre-)analytical variability; Alzheimer’s disease; biomarkers; cerebrospinal fluid; diagnostic accuracy; differential dementia diagnosis
references.citation: Biomark Med. 2012 Aug;6(4):409-17
references.pmid: 22917143
references.citation: PLoS One. 2014 Jun 24;9(6):e100784
references.pmid: 24959687
references.citation: Alzheimers Dement. 2016 May;12(5):517-26
references.pmid: 26555316
references.citation: Arch Neurol. 2011 Sep;68(9):1137-44
references.pmid: 21555603
references.citation: J Alzheimers Dis. 2014;42(4):1239-50
references.pmid: 25024328
references.citation: Clin Chem. 2005 Feb;51(2):336-45
references.pmid: 15563479
references.citation: Alzheimers Dement. 2013 May;9(3):251-61
references.pmid: 23622690
references.citation: Ann Neurol. 2009 Apr;65(4):403-13
references.pmid: 19296504
references.citation: Clin Chem. 2010 Feb;56(2):248-53
references.pmid: 19833838
references.citation: Acta Neuropathol. 2011 May;121(5):597-609
references.pmid: 21311900
references.citation: Clin Chem. 2014 Jul;60(7):987-94
references.pmid: 24842955
references.citation: Lancet Neurol. 2014 Jun;13(6):614-29
references.pmid: 24849862
references.citation: Alzheimers Dement. 2013 Jul;9(4):406-13
references.pmid: 23141384
references.citation: J Alzheimers Dis. 2013;33(1):117-31
references.pmid: 22936010
references.citation: Alzheimers Dement. 2014 Nov;10 (6):808-17
references.pmid: 25150736
references.citation: Prog Neurobiol. 2011 Dec;95(4):491-5
references.pmid: 21821094
references.citation: Cancer. 1950 Jan;3(1):32-5
references.pmid: 15405679
references.citation: Lancet Neurol. 2006 Mar;5(3):228-34
references.pmid: 16488378
references.citation: J Alzheimers Dis. 2015 ;43(1):183-91
references.pmid: 25079805
references.citation: Acta Neuropathol. 2012 Jan;123(1):1-11
references.pmid: 22101365
references.citation: Clin Chem. 2007 May;53(5):859-65
references.pmid: 17395712
references.citation: Int J Alzheimers Dis. 2010 Sep 27;2010:null
references.pmid: 20936143
references.citation: J Intern Med. 2004 Sep;256(3):183-94
references.pmid: 15324362
references.citation: Alzheimers Dement. 2015 Jan;11(1):58-69
references.pmid: 24795085
references.citation: Front Neurol. 2015 Jun 17;6:138
references.pmid: 26136723
references.citation: Biomark Med. 2012 Aug;6(4):419-30
references.pmid: 22917144
references.citation: Clin Chem. 2013 Apr;59(4):710-2
references.pmid: 23355631
references.citation: Alzheimers Dement. 2013 May;9(3):276-83
references.pmid: 23110867
references.citation: J Alzheimers Dis. 2014;41(2):441-51
references.pmid: 24625802
references.citation: Clin Chem. 2015 May;61(5):734-43
references.pmid: 25869575
references.citation: Neurology. 2013 Mar 19;80(12 ):1124-32
references.pmid: 23446677
references.citation: Alzheimers Dement. 2011 May;7(3):280-92
references.pmid: 21514248
references.citation: Methods. 2012 Apr;56(4):484-93
references.pmid: 22503777
references.citation: Front Neurol. 2015 Jul 08;6:153
references.pmid: 26217300
references.citation: Alzheimers Dement. 2013 Mar;9(2):137-40
references.pmid: 23274154
references.citation: Alzheimers Dement. 2012 Jan;8(1):65-73
references.pmid: 22047631
references.citation: Neurobiol Aging. 2008 Aug;29(8):1143-59
references.pmid: 17428581
references.citation: J Alzheimers Dis. 2013;36(4):759-67
references.pmid: 23666174
references.citation: Neurology. 1984 Jul;34(7):939-44
references.pmid: 6610841